Learn about coronary artery bypass grafting (CABG) surgery, a life-saving procedure for severe heart disease, offering ...

Plans for filing an IND was agreed with the FDA in a recent meeting –– Positive preclinical results of the small-diameter ATEV were recently ...

In addition, some patients do not have usable saphenous vein available for surgical bypass. “Coronary artery bypass graft (CABG) surgery can be lifesaving in appropriately selected patients with ...

DURHAM, N.C. - Humacyte, Inc. (NASDAQ:HUMA), a biotechnology company valued at $567 million, has announced its intention to file an Investigational New Drug (IND) application with the U.S. Food and ...

Humacyte (HUMA) announced that it plans to file an Investigational New Drug, IND, application with the U.S. Food and Drug Administration, FDA, ...